PM Images Cartesian Therapeutics ( RNAC ) jumped over 30% on Tuesday after announcing a licensing deal to develop its CAR-T cell therapies using a drug delivery technology developed by the mRNA therapeutics company WestGene Biopharma. Under the collaboration, a Phase 1 dose-escalation study will get underway to test the potential of delivering mRNA used in Cartesian’s lead asset Descartes-08 via W...
PM Images Cartesian Therapeutics ( RNAC ) jumped over 30% on Tuesday after announcing a licensing deal to develop its CAR-T cell therapies using a drug delivery technology developed by the mRNA therapeutics company WestGene Biopharma. Under the collaboration, a Phase 1 dose-escalation study will get underway to test the potential of delivering mRNA used in Cartesian’s lead asset Descartes-08 via WestGene’s targeted lipid nanoparticles (LNP) for patients with generalized myasthenia gravis. Additionally, the Maryland-based biotech said that it plans to advance several of its next-generation anti-BCMA CAR constructs and a BCMA-directed T-cell engager as part of the deal in a bid to expand its mRNA payload pipeline. “With positive clinical data, we intend to advance programs across multiple autoimmune diseases into U.S. clinical development,” CEO Carsten Brunn added. “We believe this collaboration has the potential to further transform the treatment paradigm for cell therapy in autoimmune diseases.” Per the terms, the Chinese biotech will receive an upfront payment from Cartesian with the potential for additional development and commercial-based milestone payments. The Phase 1 trial is scheduled to begin in H2 2026, with in-human data expected in H1 2027. More on Cartesian Therapeutics Cartesian Therapeutics: A Phase 3 mRNA CAR-T Bet Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript Cartesian Therapeutics GAAP EPS of -$1.46 misses by $0.58 Seeking Alpha’s Quant Rating on Cartesian Therapeutics Historical earnings data for Cartesian Therapeutics
ZenaTech ( ZENA ) on Tuesday said it has been added as a member of the broad-market Russell 3000 Index effective at market open on June 29, 2026, as part of the first 2026 Russell indexes reconstitution. ZENA stock is up 3.2% at $1.44. The June reconstitution of the Russell US indexes captures up to the 4,000 largest US stocks, ranking them by total market capitalization. More on ZenaTech ZenaTech...
ZenaTech ( ZENA ) on Tuesday said it has been added as a member of the broad-market Russell 3000 Index effective at market open on June 29, 2026, as part of the first 2026 Russell indexes reconstitution. ZENA stock is up 3.2% at $1.44. The June reconstitution of the Russell US indexes captures up to the 4,000 largest US stocks, ranking them by total market capitalization. More on ZenaTech ZenaTech: I Like The Story, But Not The Numbers ZenaTech: Navigating High Growth, Dilution, And Government Contract Potential ZenaTech: Drone-As-A-Service Rollup Play With Explosive Growth, But Dilution Looms Ondas leads drone stocks Quant rating as sector surges on potential funding Drone stocks rally after report Trump administration explores funding deals
“I think it’s the most exciting period in cancer discovery and development that I’ve experienced over the last 25 years,” says Susan Galbraith, executive vice president of oncology R&D at AstraZeneca. Galbraith joins Bloomberg Intelligence analyst Sam Fazeli fresh from the ASCO conference to unpack how ctDNA, earlier intervention and next-generation oncology platforms could reshape cancer care. Th...
“I think it’s the most exciting period in cancer discovery and development that I’ve experienced over the last 25 years,” says Susan Galbraith, executive vice president of oncology R&D at AstraZeneca. Galbraith joins Bloomberg Intelligence analyst Sam Fazeli fresh from the ASCO conference to unpack how ctDNA, earlier intervention and next-generation oncology platforms could reshape cancer care. They discuss AstraZeneca’s Stride regimen in liver cancer, Serena-6 in breast cancer, progress in
Corn price action is up 2 ½ to 3 ½ cents so far on Tuesday AM trade. Futures closed the Monday session with front months fractionally to 1 ¼ cents higher, as other contracts were steady to 1 ¾ cents lower. Open interest was down 4,667 contracts, as 40,717 contracts...
Corn price action is up 2 ½ to 3 ½ cents so far on Tuesday AM trade. Futures closed the Monday session with front months fractionally to 1 ¼ cents higher, as other contracts were steady to 1 ¾ cents lower. Open interest was down 4,667 contracts, as 40,717 contracts...
Eric Trump, left, and Donald Trump Jr. pose for pictures outside the Nasdaq MarketSite after ringing the opening bell to celebrate the closing of Alt5 Sigma’s adoption of its cryptocurrency deal with World Liberty Financial, in New York, Aug. 13, 2025. Eduardo Munoz | Reuters Back in August, Eric Trump and Donald Trump Jr. were all smiles. They showed up at the Nasdaq stock exchange in New York to...
Eric Trump, left, and Donald Trump Jr. pose for pictures outside the Nasdaq MarketSite after ringing the opening bell to celebrate the closing of Alt5 Sigma’s adoption of its cryptocurrency deal with World Liberty Financial, in New York, Aug. 13, 2025. Eduardo Munoz | Reuters Back in August, Eric Trump and Donald Trump Jr. were all smiles. They showed up at the Nasdaq stock exchange in New York to celebrate a new business partnership with a little-known publicly traded company, then called Alt5 Sigma , to give investors easier access to a cryptocurrency backed by the Trump family. Less than 10 months later, the company has warned investors it may not be able to stay in business much longer. Its share price has fallen more than 90%, and a rebranding hasn't revived investor interest. If the company, now called AI Financial Corp., can't sustainably raise its share price out of penny-stock levels in the next 15 trading days, it faces the prospect of being delisted by the Nasdaq. One of the few parties who benefited from the Alt5 Sigma transaction is the Trump family. As part of the August deal, Alt5 acquired $1.5 billion worth of crypto tokens from World Liberty Financial, the crypto company co-founded by Eric Trump and Donald Trump Jr., among others, in 2024. The president and undisclosed members of his family were entitled to roughly $500 million in proceeds from the crypto sale, according to disclosures by World Liberty Financial . Alt5 closed at $8.97 on Aug. 8, the last trading day before the World Liberty deal was announced. Since then, AI Financial 's stock — originally trading under the ticker ALTS, now AIFC — fell to 66 cents a share at the June 8 close, a 93% loss, according to FactSet data. Attorneys for Democracy Defenders Fund told the Securities and Exchange Commission in an April letter that the regulator needs to "commence an independent investigation into ALTS without delay." The nonpartisan group has sharply criticized the Trump administration over all...
Gold is weird. It's one of the few metals that doesn’t really oxidize. Even silver and copper—from the same column of the periodic table—form weak oxides. Naively, you might expect that gold would tarnish just like silver. Gold also sits right next to platinum, but it has none of that metal’s catalytic properties. Then came gold nanoparticles that acted like catalysts, and we were confused by thei...
Gold is weird. It's one of the few metals that doesn’t really oxidize. Even silver and copper—from the same column of the periodic table—form weak oxides. Naively, you might expect that gold would tarnish just like silver. Gold also sits right next to platinum, but it has none of that metal’s catalytic properties. Then came gold nanoparticles that acted like catalysts, and we were confused by their apparent willingness to take part in chemical reactions. Now, a pair of scientists has explained that gold’s inertness isn’t inherent to the atom but rather to the surfaces that gold crystals form. Before we get to the results, let’s first take a look at the traditional explanation for gold’s inertness and why an inert material that has no catalytic activity suddenly acts as a catalyst when in its nanoparticle form. Read full article Comments
EHang ( EH ) reported a sharp deterioration in first-quarter results , sending its shares down more than 18% in trading after the autonomous electric aircraft maker posted revenue well below expectations and significantly wider losses. The company reported first-quarter revenue of RMB25.7M (US$3.7M), up 2.8% from a year earlier but missing analyst estimates by ~US$4.27M. Non-GAAP loss per ADS came...
EHang ( EH ) reported a sharp deterioration in first-quarter results , sending its shares down more than 18% in trading after the autonomous electric aircraft maker posted revenue well below expectations and significantly wider losses. The company reported first-quarter revenue of RMB25.7M (US$3.7M), up 2.8% from a year earlier but missing analyst estimates by ~US$4.27M. Non-GAAP loss per ADS came in at US$0.14. Net loss widened to RMB126.4M (US$18.3M), compared with RMB78.4M in the year-ago period, while operating loss increased to RMB127.9M. On a non-GAAP basis, adjusted net loss was RMB75.6M, reversing from adjusted profitability achieved in the previous quarter. Despite the weak quarter, EHang maintained its full-year 2026 revenue guidance of around RMB600M, citing expected progress toward commercial operations in China, international expansion opportunities, and growing contributions from its aerial media business, which accounted for about 40% of first-quarter revenue. The company ended March with RMB1.03B (US$148.9M) in cash, investments and treasury balances. EHang also announced a new share repurchase program authorizing up to US$30M in buybacks over the next 12 months, underscoring management's confidence in its long-term growth prospects. More on EHang EHang: From Bleeding On Paper To Thriving In Reality EHang Holdings Limited 2025 Q4 - Results - Earnings Call Presentation EHang Holdings Limited (EH) Q4 2025 Earnings Call Transcript EHang Non-GAAP EPADS of -$0.14, revenue of $3.7M misses by $4.27M; reaffirms FY2026 outlook EHang Q1 Earnings Preview
Tory leader takes aim at police guidance and says more black boys searched means more black lives saved UK politics live – latest updates Kemi Badenoch has argued that Britain took a wrong turn after the landmark Macpherson report into the racist killing of Stephen Lawrence, and said that it didn’t matter how many young black boys were stopped and searched by police. The Conservative leader made t...
Tory leader takes aim at police guidance and says more black boys searched means more black lives saved UK politics live – latest updates Kemi Badenoch has argued that Britain took a wrong turn after the landmark Macpherson report into the racist killing of Stephen Lawrence, and said that it didn’t matter how many young black boys were stopped and searched by police. The Conservative leader made the comments as she announced plans to scrap the obligation on public bodies to consider how they can promote equality as she seeks to head off the challenge to her party from Reform UK. Continue reading...
Maskot/DigitalVision via Getty Images Payoneer Global ( PAYO ) soared 14% on a report that Nuvei is in talks to acquire the cross-border payments company at a deal valued at $2.3 billion, including debt, according to a Reuters report on Tuesday. Developing story ... More on Payoneer Global Payoneer: The B2B Shift Is Working, But Growth Still Looks Too Slow Payoneer Global Inc. 2026 Q1 - Results - ...
Maskot/DigitalVision via Getty Images Payoneer Global ( PAYO ) soared 14% on a report that Nuvei is in talks to acquire the cross-border payments company at a deal valued at $2.3 billion, including debt, according to a Reuters report on Tuesday. Developing story ... More on Payoneer Global Payoneer: The B2B Shift Is Working, But Growth Still Looks Too Slow Payoneer Global Inc. 2026 Q1 - Results - Earnings Call Presentation Payoneer Global Inc. (PAYO) Q1 2026 Earnings Call Transcript Payoneer forecasts $1.1B-$1.14B 2026 revenue as it targets mid-teens exit growth Payoneer Global Q1 2026 Earnings Preview
Igor Alecsander/iStock Unreleased via Getty Images In an effort to attract new riders with a U.S.-made, performance-driven motorcycle, Harley-Davidson ( HOG ) is bringing back its Revolution Max platform to North American manufacturing as part of the company’s Back to Bricks strategy. The Revolution Max is a V-twin engine platform designed for high performance and versatility. The liquid-cooled mo...
Igor Alecsander/iStock Unreleased via Getty Images In an effort to attract new riders with a U.S.-made, performance-driven motorcycle, Harley-Davidson ( HOG ) is bringing back its Revolution Max platform to North American manufacturing as part of the company’s Back to Bricks strategy. The Revolution Max is a V-twin engine platform designed for high performance and versatility. The liquid-cooled motor (vs. more traditional air-cooled motors) provides greater efficiency, can run at max capacity for longer, and with more consistent power. The Revolution Max is currently used to manufacture the Nightster and Pan American, both of which are made in Thailand and assembled in the U.S., and will be used to reintroduce the Sportster. Harley-Davidson ( HOG ) is bringing the platform back to U.S. manufacturing at facilities in Pennsylvania and Wisconsin and is expected to be completed ahead of the start of model year 2028. The company plans to make over 100K motorcycles out of its York, PA facility in 2027. “The Trump Administration's changes to U.S. trade policy, combined with shifts in the global trade environment, have created new opportunities for companies to invest in domestic manufacturing. For Harley-Davidson under our new CEO Artie Starrs, this means we are able to lean even further into our American manufacturing footprint and build more motorcycles here at home. This decision, which has been months in the making, reflects our commitment to strengthening Harley-Davidson's manufacturing base for the long term,” the company said in a statement . Beyond the favorable optics, the move back to the U.S. could also be driven by financial considerations. The company has seen sales deteriorate by as much as 20% since 2021, culminating in an operating loss of $361M by Q4 2025. Under new CEO Artie Starrs, the company was able to deliver a modest improvement in sales and reduce global inventory by 22% year-over-year. To continue the positive momentum, Starrs outlined the company...